ExpMED RZ
ActiveSummary
ExpMED RZ has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €89,761 and a net result of €49,049. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 41% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2025
29-12
NBB filing
Annual accounts filed
financial year 2025 · micro format
2024
17-12
NBB filing
Annual accounts filed
financial year 2024 · micro format
30-06
Financial
Back to profitnet €51,245
Net result €51,245 after one loss-making year.
2023
30-11
NBB filing
Annual accounts filed
financial year 2023 · micro format
30-06
Financial
Weakest financial yearnet -€90,814
Net result drops to -€90,814, the lowest in the series; recovery starts the following year.
2022
05-12
NBB filing
Annual accounts filed
financial year 2022 · micro format
30-06
Financial
Highest result from 2020 to 2025net €136,984 ▲113%
Operating result €180,018, net result €136,984, both a record.
2021
29-12
NBB filing
Annual accounts filed
financial year 2021 · micro format
29-01
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.